Universal CAR-T Cell Therapy for MM
Conditions
- Multiple Myeloma
- Multiple Myeloma in Relapse
- Multiple Myeloma, Refractory
Interventions
- DRUG: Targeted BCMA Gene-Modified Allogeneic Chimeric Antigen Receptor T-Cell Injection
Sponsor
Bioray Laboratories
Collaborators